Prediction of Adverse Events during Intensive Induction Chemotherapy for Acute Myeloid Leukemia or High-Grade Myelodysplastic Syndromes

Intensive chemotherapy for newly diagnosed acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS) is associated with significant treatment-related morbidity and mortality. Herein, we investigate how pre-treatment characteristics relate to early adverse outcomes in such patients. Among 205 c...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Hematol
Asıl Yazarlar: Buckley, Sarah A., Othus, Megan, Vainstein, Vladimir, Abkowitz, Janis L., Estey, Elihu H., Walter, Roland B.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4391649/
https://ncbi.nlm.nih.gov/pubmed/24382796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.23661
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller